E46: Why is AI essential for developing new medicines for genetic diseases?
Catch the Ask AI interview with Amit Deshwar, VP and Head of Predictive Systems at Deep Genomics, the AI Workbench used to prioritize transformational RNA therapeutics for genetic diseases
Click here to subscribe to our podcast and newsletter. Our special thanks to Microsoft Canada and Cinchy, the Dataware platform for sponsoring the 4th series of the Ask AI podcast.
Amit Deshwar is the Vice President and Head of Predictive Systems at Deep Genomics. Under his leadership, Deep Genomics has developed more than 40 machine learning models of molecular phenotype and developed novel GalNAc hepatocyte delivery technology. Recently his team has released the AI Workbench 2.0, that fuses deep mechanistic understanding of SBO activity, predictive models and high throughput sequencing datasets that enables rapid development of expression increase SBOs.
Prior to Deep Genomics, he worked at Google where he built a highly distributed log parsing system and power supply firmware that enabled co-ordinated reductions in peak power consumption. In addition, he founded a startup that matches employers and potential employees using predictive models of personality and workplace attributes.
Amit received bachelor degrees in Software Engineering and Psychology from the University of Calgary. His Phd is from the University of Toronto, where he studied machine learning for oncology, and built tree-structured Baysesian nonparametric models for untangling the complex biology of intra-tumour heterogeneity.
Tune in to this Ask AI interview host Melissa Kargianakkis meets Amit Deshwar, VP and Head of Predictive Systems at Deep Genomics, to ask the question:
Why is AI essential for developing transformative medicines for genetic diseases?
Or search "Ask AI" wherever you get your shows
Like, share, or leave a comment on our social posts for this episode! 😍
Talk to our bot
This episode and hundreds of AI resources are available from the Ask AI chatbot - big thanks to our technology partner Ada for providing this World-class made-in-Canada technology!
Deep Genomics Raises $180M in Series C Financing (July 2021)
You might also like
How is AI being used to help predict breast cancer?
The Ask AI interview with Dr. Samuel Aparicio, Chair in Breast Cancer Research at UBC and Head of the BC Cancer Research Institute Department of Breast and Molecular Oncology.
How is Cohere building a global NLP powerhouse?
Catch our Team Check-in with Ivan Zhang, co-founder at Cohere, the Toronto NLP startup that recently raised $125M CAD to fund its global expansion
About Ask AI
Ask AI is a volunteer project exploring Canada's fast-emerging artificial intelligence sector. Our projects include thought leader interviews, team check-ins, and live events. To learn more about sponsorships, guest blogs, and volunteering, please contact us or ask our chatbot.